Concepts (177)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Guideline Adherence | 7 | 2019 | 288 | 0.810 |
Why?
|
| Quality Assurance, Health Care | 6 | 2014 | 251 | 0.700 |
Why?
|
| Evidence-Based Medicine | 6 | 2010 | 440 | 0.510 |
Why?
|
| Myocardial Infarction | 4 | 2010 | 859 | 0.490 |
Why?
|
| Practice Guidelines as Topic | 7 | 2015 | 700 | 0.400 |
Why?
|
| Angioplasty, Balloon, Coronary | 3 | 2009 | 167 | 0.400 |
Why?
|
| American Heart Association | 2 | 2010 | 122 | 0.400 |
Why?
|
| Disease Management | 4 | 2004 | 220 | 0.350 |
Why?
|
| Awards and Prizes | 1 | 2010 | 31 | 0.340 |
Why?
|
| Program Evaluation | 3 | 2010 | 471 | 0.330 |
Why?
|
| Referral and Consultation | 2 | 2009 | 398 | 0.290 |
Why?
|
| Quality Improvement | 3 | 2019 | 413 | 0.260 |
Why?
|
| Point-of-Care Systems | 1 | 2007 | 119 | 0.250 |
Why?
|
| Cardiology | 1 | 2007 | 163 | 0.250 |
Why?
|
| Societies, Medical | 1 | 2007 | 332 | 0.240 |
Why?
|
| Heart Failure | 2 | 2008 | 852 | 0.210 |
Why?
|
| Thrombolytic Therapy | 3 | 2015 | 184 | 0.200 |
Why?
|
| Stroke | 5 | 2015 | 1123 | 0.190 |
Why?
|
| Diffusion of Innovation | 1 | 2001 | 56 | 0.180 |
Why?
|
| Registries | 4 | 2019 | 795 | 0.180 |
Why?
|
| Computer Systems | 1 | 2019 | 14 | 0.160 |
Why?
|
| Brain Ischemia | 2 | 2015 | 399 | 0.160 |
Why?
|
| Quality of Health Care | 3 | 2008 | 510 | 0.160 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 148 | 0.150 |
Why?
|
| Mortality | 1 | 2019 | 154 | 0.150 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 98 | 0.150 |
Why?
|
| ST Elevation Myocardial Infarction | 1 | 2019 | 73 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2015 | 683 | 0.140 |
Why?
|
| Machine Learning | 1 | 2019 | 153 | 0.140 |
Why?
|
| Cardiovascular Diseases | 4 | 2009 | 788 | 0.140 |
Why?
|
| United States | 9 | 2019 | 7370 | 0.140 |
Why?
|
| Attitude of Health Personnel | 1 | 2001 | 548 | 0.140 |
Why?
|
| Coronary Artery Disease | 2 | 2010 | 273 | 0.140 |
Why?
|
| Hospital Mortality | 5 | 2019 | 836 | 0.130 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2019 | 160 | 0.130 |
Why?
|
| Physicians | 1 | 2001 | 423 | 0.130 |
Why?
|
| Electronic Health Records | 1 | 2019 | 341 | 0.130 |
Why?
|
| Hospitals | 2 | 2010 | 373 | 0.130 |
Why?
|
| Patient Care Team | 2 | 2014 | 325 | 0.120 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 255 | 0.120 |
Why?
|
| Hyperglycemia | 1 | 2015 | 98 | 0.120 |
Why?
|
| Teaching Rounds | 1 | 2014 | 11 | 0.120 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 125 | 0.120 |
Why?
|
| Fibrinolytic Agents | 1 | 2015 | 162 | 0.110 |
Why?
|
| Middle Aged | 11 | 2019 | 16240 | 0.110 |
Why?
|
| Risk Assessment | 2 | 2019 | 1898 | 0.110 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 137 | 0.100 |
Why?
|
| Blood Glucose | 1 | 2015 | 461 | 0.100 |
Why?
|
| Humans | 23 | 2019 | 59106 | 0.100 |
Why?
|
| Diabetes Mellitus | 1 | 1997 | 515 | 0.100 |
Why?
|
| Achievement | 1 | 2010 | 27 | 0.090 |
Why?
|
| Prescriptions | 1 | 2010 | 30 | 0.090 |
Why?
|
| Ticlopidine | 1 | 2010 | 45 | 0.090 |
Why?
|
| Female | 12 | 2019 | 30613 | 0.080 |
Why?
|
| Aged | 9 | 2019 | 13348 | 0.080 |
Why?
|
| Patient Care | 1 | 2010 | 77 | 0.080 |
Why?
|
| Time and Motion Studies | 1 | 2009 | 14 | 0.080 |
Why?
|
| Health Care Surveys | 1 | 2010 | 270 | 0.080 |
Why?
|
| Global Health | 1 | 2010 | 167 | 0.080 |
Why?
|
| Risk Reduction Behavior | 1 | 2009 | 120 | 0.080 |
Why?
|
| Health Promotion | 2 | 2009 | 471 | 0.070 |
Why?
|
| Male | 11 | 2019 | 27623 | 0.070 |
Why?
|
| Ischemic Attack, Transient | 1 | 2008 | 90 | 0.070 |
Why?
|
| Occupational Health | 1 | 2009 | 180 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2009 | 263 | 0.070 |
Why?
|
| Personnel, Hospital | 1 | 2007 | 40 | 0.070 |
Why?
|
| Kidney Diseases | 1 | 2008 | 166 | 0.070 |
Why?
|
| Joint Commission on Accreditation of Healthcare Organizations | 2 | 2009 | 7 | 0.070 |
Why?
|
| Safety | 1 | 2007 | 141 | 0.070 |
Why?
|
| Chronic Disease | 3 | 2015 | 714 | 0.060 |
Why?
|
| Triage | 1 | 2007 | 108 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2006 | 523 | 0.060 |
Why?
|
| Risk Factors | 4 | 2019 | 4948 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2015 | 5227 | 0.060 |
Why?
|
| Case Management | 1 | 2004 | 54 | 0.060 |
Why?
|
| Peptic Ulcer | 1 | 2003 | 20 | 0.050 |
Why?
|
| Algorithms | 2 | 2019 | 974 | 0.050 |
Why?
|
| Time Factors | 3 | 2019 | 3586 | 0.050 |
Why?
|
| Managed Care Programs | 1 | 2003 | 88 | 0.050 |
Why?
|
| Retrospective Studies | 3 | 2019 | 6030 | 0.050 |
Why?
|
| Academic Medical Centers | 2 | 2008 | 305 | 0.050 |
Why?
|
| Planning Techniques | 1 | 2001 | 14 | 0.050 |
Why?
|
| Massachusetts | 1 | 2007 | 2004 | 0.050 |
Why?
|
| Information Systems | 1 | 2001 | 29 | 0.050 |
Why?
|
| Inservice Training | 1 | 2001 | 82 | 0.040 |
Why?
|
| Heart Block | 1 | 1980 | 22 | 0.040 |
Why?
|
| Acute Disease | 2 | 2015 | 656 | 0.040 |
Why?
|
| Disopyramide | 1 | 1980 | 11 | 0.040 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 896 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 2 | 1980 | 96 | 0.040 |
Why?
|
| Ion Channels | 1 | 1980 | 88 | 0.040 |
Why?
|
| Pyridines | 1 | 1980 | 98 | 0.040 |
Why?
|
| Leadership | 1 | 2001 | 193 | 0.040 |
Why?
|
| Logistic Models | 2 | 2015 | 1223 | 0.040 |
Why?
|
| Guidelines as Topic | 2 | 2009 | 153 | 0.040 |
Why?
|
| Forecasting | 2 | 2009 | 219 | 0.040 |
Why?
|
| Health Care Rationing | 1 | 1998 | 21 | 0.040 |
Why?
|
| Models, Economic | 1 | 1998 | 43 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 1 | 1997 | 103 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2019 | 3052 | 0.040 |
Why?
|
| Critical Pathways | 1 | 1997 | 31 | 0.040 |
Why?
|
| Canada | 1 | 1998 | 145 | 0.040 |
Why?
|
| Risk | 1 | 1997 | 364 | 0.030 |
Why?
|
| Survival Rate | 1 | 2019 | 797 | 0.030 |
Why?
|
| Inpatients | 1 | 2019 | 289 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 1998 | 203 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 1998 | 112 | 0.030 |
Why?
|
| Health Care Costs | 1 | 1997 | 203 | 0.030 |
Why?
|
| Incidence | 1 | 2019 | 1226 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2015 | 402 | 0.030 |
Why?
|
| Pilot Projects | 1 | 1998 | 913 | 0.030 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 40 | 0.030 |
Why?
|
| Hospitals, Teaching | 1 | 2014 | 102 | 0.030 |
Why?
|
| Awareness | 1 | 2014 | 73 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2015 | 736 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 2330 | 0.030 |
Why?
|
| Comorbidity | 2 | 2008 | 1077 | 0.030 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 5101 | 0.030 |
Why?
|
| Length of Stay | 1 | 2015 | 769 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 330 | 0.020 |
Why?
|
| Arrhythmias, Cardiac | 3 | 1980 | 144 | 0.020 |
Why?
|
| Biomarkers | 1 | 2015 | 1304 | 0.020 |
Why?
|
| Utah | 1 | 2009 | 7 | 0.020 |
Why?
|
| Verapamil | 2 | 1980 | 9 | 0.020 |
Why?
|
| Occupational Health Services | 1 | 2009 | 36 | 0.020 |
Why?
|
| Aspirin | 1 | 2010 | 166 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 452 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2009 | 146 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2010 | 210 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2008 | 70 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2008 | 65 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2014 | 1184 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 441 | 0.020 |
Why?
|
| Sex Factors | 1 | 2009 | 934 | 0.020 |
Why?
|
| Health Planning Guidelines | 1 | 2006 | 31 | 0.020 |
Why?
|
| Myocardial Reperfusion | 1 | 2006 | 24 | 0.020 |
Why?
|
| Administrative Personnel | 1 | 2006 | 29 | 0.020 |
Why?
|
| Diagnosis-Related Groups | 1 | 2006 | 86 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 1499 | 0.020 |
Why?
|
| Peer Review, Health Care | 1 | 2004 | 17 | 0.010 |
Why?
|
| Conflict of Interest | 1 | 2004 | 36 | 0.010 |
Why?
|
| Proton Pumps | 1 | 2003 | 7 | 0.010 |
Why?
|
| Anti-Ulcer Agents | 1 | 2003 | 8 | 0.010 |
Why?
|
| Angina Pectoris | 2 | 1980 | 37 | 0.010 |
Why?
|
| Gastric Acid | 1 | 2003 | 10 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2004 | 129 | 0.010 |
Why?
|
| Helicobacter pylori | 1 | 2003 | 58 | 0.010 |
Why?
|
| Exercise | 1 | 2009 | 883 | 0.010 |
Why?
|
| Coronary Disease | 2 | 1980 | 244 | 0.010 |
Why?
|
| Health Expenditures | 1 | 2003 | 113 | 0.010 |
Why?
|
| Health Services Research | 1 | 2003 | 265 | 0.010 |
Why?
|
| Medicare | 1 | 2006 | 598 | 0.010 |
Why?
|
| Hospitalization | 1 | 2008 | 1288 | 0.010 |
Why?
|
| Adult | 3 | 2009 | 15615 | 0.010 |
Why?
|
| Procainamide | 1 | 1980 | 6 | 0.010 |
Why?
|
| Diltiazem | 1 | 1980 | 3 | 0.010 |
Why?
|
| Nifedipine | 1 | 1980 | 18 | 0.010 |
Why?
|
| Physician-Patient Relations | 1 | 2004 | 395 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2004 | 452 | 0.010 |
Why?
|
| Sodium | 1 | 1980 | 60 | 0.010 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1980 | 47 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1980 | 85 | 0.010 |
Why?
|
| Heart Conduction System | 1 | 1980 | 50 | 0.010 |
Why?
|
| Heart Atria | 1 | 1980 | 135 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1980 | 115 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 4250 | 0.010 |
Why?
|
| Muscles | 1 | 1980 | 173 | 0.010 |
Why?
|
| Calcium | 1 | 1980 | 553 | 0.010 |
Why?
|
| Quality of Life | 1 | 2003 | 1134 | 0.010 |
Why?
|
| Atrial Fibrillation | 1 | 1980 | 805 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1980 | 21 | 0.000 |
Why?
|
| Coronary Circulation | 1 | 1978 | 50 | 0.000 |
Why?
|
| Echocardiography | 1 | 1980 | 457 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1978 | 230 | 0.000 |
Why?
|
| Kinetics | 1 | 1978 | 750 | 0.000 |
Why?
|
| Hypertension | 1 | 1978 | 567 | 0.000 |
Why?
|
| Animals | 1 | 1978 | 19589 | 0.000 |
Why?
|